IL236476A0 - Preparations and methods for the treatment or prevention of infection with the pneumovirus and diseases related to it - Google Patents

Preparations and methods for the treatment or prevention of infection with the pneumovirus and diseases related to it

Info

Publication number
IL236476A0
IL236476A0 IL236476A IL23647614A IL236476A0 IL 236476 A0 IL236476 A0 IL 236476A0 IL 236476 A IL236476 A IL 236476A IL 23647614 A IL23647614 A IL 23647614A IL 236476 A0 IL236476 A0 IL 236476A0
Authority
IL
Israel
Prior art keywords
compositions
treating
preventing
methods
virus infection
Prior art date
Application number
IL236476A
Other languages
English (en)
Hebrew (he)
Original Assignee
Microdose Therapeutx Inc
Cook Robert O
Reynolds Eugene R
Shekunov Boris
Zegar Siead I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microdose Therapeutx Inc, Cook Robert O, Reynolds Eugene R, Shekunov Boris, Zegar Siead I filed Critical Microdose Therapeutx Inc
Publication of IL236476A0 publication Critical patent/IL236476A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL236476A 2012-06-29 2014-12-25 Preparations and methods for the treatment or prevention of infection with the pneumovirus and diseases related to it IL236476A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261666258P 2012-06-29 2012-06-29
PCT/US2013/048723 WO2014005098A2 (en) 2012-06-29 2013-06-28 Compositions and methods for treating or preventing pneumovirus infection and associated diseases

Publications (1)

Publication Number Publication Date
IL236476A0 true IL236476A0 (en) 2015-02-26

Family

ID=49778754

Family Applications (1)

Application Number Title Priority Date Filing Date
IL236476A IL236476A0 (en) 2012-06-29 2014-12-25 Preparations and methods for the treatment or prevention of infection with the pneumovirus and diseases related to it

Country Status (17)

Country Link
US (2) US9040569B2 (cg-RX-API-DMAC7.html)
EP (1) EP2867216A4 (cg-RX-API-DMAC7.html)
JP (1) JP2015524391A (cg-RX-API-DMAC7.html)
KR (1) KR20150037946A (cg-RX-API-DMAC7.html)
CN (1) CN104507918A (cg-RX-API-DMAC7.html)
AU (1) AU2013282286A1 (cg-RX-API-DMAC7.html)
BR (1) BR112014032290A2 (cg-RX-API-DMAC7.html)
CA (1) CA2877941A1 (cg-RX-API-DMAC7.html)
EA (1) EA201590124A1 (cg-RX-API-DMAC7.html)
HK (2) HK1203956A1 (cg-RX-API-DMAC7.html)
IL (1) IL236476A0 (cg-RX-API-DMAC7.html)
IN (1) IN2014DN10680A (cg-RX-API-DMAC7.html)
MX (1) MX2014015340A (cg-RX-API-DMAC7.html)
NZ (1) NZ628880A (cg-RX-API-DMAC7.html)
TW (1) TWI516283B (cg-RX-API-DMAC7.html)
WO (1) WO2014005098A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201409073B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014005098A2 (en) 2012-06-29 2014-01-03 Microdose Therapeutx, Inc. Compositions and methods for treating or preventing pneumovirus infection and associated diseases
WO2016096143A1 (de) * 2014-12-18 2016-06-23 Metriopharm Ag Kristalline form von 5-amino-2,3-dihydrophthalazin-1,4-dion natriumsalz, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
KR20180105129A (ko) * 2015-11-30 2018-09-27 노부스 테라퓨틱스, 인크. 이과학적 예방 및 치료를 위한 조성물 및 방법
US10238821B2 (en) 2016-10-11 2019-03-26 Microdose Therapeutx, Inc. Inhaler and methods of use thereof
KR20240119159A (ko) * 2018-09-14 2024-08-06 파모사 바이오팜 인코포레이티드 약산성 약물의 방출 제어를 위한 약제학적 조성물 및 이의 용도
CN109827875A (zh) * 2019-04-10 2019-05-31 上海市食品药品检验所 一种用于测定吸入制剂溶出度的装置和方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ505894A (en) * 1998-01-29 2002-12-20 Viropharma Inc Methylenebisbenzaldehyde derivatives, methylidynetrisphenol derivative and pharmaceuticals thereof; useful for treating or preventing pneumovirus infection and associated diseases
US6495580B1 (en) * 1998-01-29 2002-12-17 Viropharma Incorporated Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
WO2002059132A1 (en) 2001-01-26 2002-08-01 Viropharma Incorporated Intermediate compounds useful for making antiviral compounds
AU2003258177A1 (en) * 2002-08-09 2004-02-25 Viropharma Incorporated Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
AU2003258176A1 (en) 2002-08-09 2004-02-25 Viropharma Incorporated Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
WO2014005098A2 (en) 2012-06-29 2014-01-03 Microdose Therapeutx, Inc. Compositions and methods for treating or preventing pneumovirus infection and associated diseases

Also Published As

Publication number Publication date
US20150209328A1 (en) 2015-07-30
US20140005239A1 (en) 2014-01-02
IN2014DN10680A (cg-RX-API-DMAC7.html) 2015-08-28
WO2014005098A2 (en) 2014-01-03
WO2014005098A3 (en) 2014-02-27
NZ628880A (en) 2016-08-26
US9504672B2 (en) 2016-11-29
TW201416093A (zh) 2014-05-01
TWI516283B (zh) 2016-01-11
US9040569B2 (en) 2015-05-26
AU2013282286A1 (en) 2015-01-22
ZA201409073B (en) 2016-08-31
EA201590124A1 (ru) 2015-06-30
MX2014015340A (es) 2015-03-05
EP2867216A4 (en) 2015-12-09
CN104507918A (zh) 2015-04-08
JP2015524391A (ja) 2015-08-24
CA2877941A1 (en) 2014-01-03
HK1210163A1 (en) 2016-04-15
EP2867216A2 (en) 2015-05-06
HK1203956A1 (en) 2015-11-06
BR112014032290A2 (pt) 2017-06-27
KR20150037946A (ko) 2015-04-08

Similar Documents

Publication Publication Date Title
IL267997A (en) Preparations, formulations and methods for treating eye diseases
IL236054B (en) Compositions and methods for treating Crohn's disease and related conditions and infections
IL244431A0 (en) Pharmacy methods and preparations for the treatment of hepatitis b virus infection
WO2014052836A3 (en) Methods and compositions for treating infection
BR112013020425A2 (pt) composições e métodos para o tratamento ou prevenção de infecção por vírus da hepatite b
DK3292875T3 (en) Compositions and methods for treating diseases
HUE041553T2 (hu) Lizoszomális tárolási betegségek (LSD) kezelése és génterápia
EP2817018A4 (en) METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS
SG11201500439RA (en) Vaccine compositions for prevention against dengue virus infection
GB2503066B (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
EP2928470A4 (en) THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS
EP2869821A4 (en) COMPOSITIONS AND METHODS FOR TREATING AND INHIBITING VIRAL INFECTIONS
EP2978449A4 (en) Compositions and methods for the treatment or prevention of human immunodeficiency virus infection
IL236476A0 (en) Preparations and methods for the treatment or prevention of infection with the pneumovirus and diseases related to it
HUE050413T2 (hu) Kompozíciók és eljárások fertõzéses megbetegedés kezelésére
EP3166637A4 (en) Compositions and methods for treating dengue virus infection
ZA201307019B (en) Compositions for preventing and/or treating and infection by an hiv-1 virus
IL221399A0 (en) Compositions and methods for treating viral diseases
PL2838903T3 (pl) Sposoby i kompozycje do leczenia zakażeń wirusowych
EP2838526A4 (en) MATERIALS AND METHODS FOR PREVENTING AND TREATING VIRAL INFECTIONS
AU2012905097A0 (en) Agents and methods for inhibiting virus infection
AU2015900546A0 (en) Agents and methods for inhibiting virus infection
AU2012902449A0 (en) Novel animal infection treatment and prophylaxis
AU2014900488A0 (en) Agents and methods for inhibiting virus infection